Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4

Molecular and Cellular Biochemistry

Volumn 337, Issue 1-2, 2010, Pages 299-305

  Gorbenko, O ^a   Panayotou, G ^b   Zhyvoloup, A ^a,c   Volkova, D ^a   Gout, I ^a,c   Filonenko, V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adipogenesis; FABP4; PPAR signaling; PTEN; Yeast two hybrid screen

Indexed keywords

FATTY ACID BINDING PROTEIN 4; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SEQUENCE; GEL FILTRATION; IMMUNOPRECIPITATION; LIPID METABOLISM; NONHUMAN; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ANIMALS; CARCINOMA; COLONIC NEOPLASMS; EMBRYO, MAMMALIAN; FATTY ACID-BINDING PROTEINS; GENE LIBRARY; HELA CELLS; HUMANS; MICE; PROTEIN BINDING; PROTEINS; PTEN PHOSPHOHYDROLASE; TWO-HYBRID SYSTEM TECHNIQUES; YEASTS;

EID: 77949655800     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0312-1     Document Type: Article

References (34)

1. L Simpson R Parsons 2001 PTEN: life as a tumor suppressor Exp Cell Res 264 29 41 10.1006/excr.2000.5130 10.1006/excr.2000.5130 1:CAS:528: DC%2BD3MXhsFOhtbk%3D 11237521 (Pubitemid 32989079)
2. ML Sulis R Parsons 2003 PTEN: from pathology to biology Trends Cell Biol 13 478 483 10.1016/S0962-8924(03)00175-2 10.1016/S0962-8924(03)00175-2 1:CAS:528:DC%2BD3sXms1ygs7w%3D 12946627 (Pubitemid 37289398)
3. T Tamguney DJ Stokoe 2007 New insights into PTEN Cell Sci 120 4071 4079 10.1242/10.1242/jcs.015230 10.1242/jcs.015230 1:CAS:528:DC%2BD1cXmtFejuw%3D%3D
4. MP Myers JP Stolarov C Eng J Li SI Wang MH Wigler R Parsons NK Tonks 1997 P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase Proc Natl Acad Sci USA 94 9052 9057 10.1073/pnas.94.17.9052 1:CAS:528:DyaK2sXls1Kmurg%3D 9256433 (Pubitemid 27357780)
5. A Gericke M Munson AH Ross 2006 Regulation of the PTEN phosphatase Gene 374 1 9 10.1016/j.jene.2006.02.024 10.1016/j.gene.2006.02.024 1:CAS:528:DC%2BD28XkvVWktLY%3D 16675164
6. T Maehama JE Dixon 1998 The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate J Biol Chem 273 13375 13378 10.1074/jbc.273.22.13375 10.1074/jbc.273.22.13375 1:CAS:528:DyaK1cXjvVejsLk%3D 9593664 (Pubitemid 28268370)
7. J Gu M Tamura R Pankov EH Danen T Takino K Matsumoto KM Yamada 1999 Shc and FAK differentially regulate cell motility and directionality modulated by PTEN J Cell Biol 146 389 403 10.1083/jcb.146.2.389 1:CAS:528:DyaK1MXkvVGmt7c%3D 10427092 (Pubitemid 29369775)
8. L Mahimainathan GG Choudhury 2004 Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase J Biol Chem 279 15258 15268 10.1074/jbc.M314328200 10.1074/jbc.M314328200 1:CAS:528:DC%2BD2cXivVKgsL0%3D 14718524 (Pubitemid 38618922)
9. X Wang X Jiang 2008 Post-translational regulation of PTEN Oncogene 27 5454 5463 10.1038/onc.2008.242 10.1038/onc.2008.242 1:CAS:528:DC%2BD1cXhtFWiur3P 18794880
10. H Okamura K Yoshida H Morimoto T Haneji 2005 PTEN expression elicited by EGR-1 transcription factor in calyculin A-induced apoptotic cells J Cell Biochem 94 117 125 10.1002/jcb.20283 10.1002/jcb.20283 1:CAS:528:DC%2BD2MXmvFGj 15517593 (Pubitemid 41420330)
11. L Patel I Pass P Coxon CP Downes SA Smith CH Macphee 2001 Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN Curr Biol 11 764 768 10.1016/S0960-9822(01)00225-1 10.1016/S0960-9822(01)00225-1 1:CAS:528:DC%2BD3MXjvFSiurg%3D 11378386 (Pubitemid 32442793)
12. RE Teresi C-W Shaiu C-S Chen VK Chatterjee KA Waite C Eng 2006 Increased PTEN expression due to transcriptional activation of PPARγ by lovastatin and rosiglitazone Int J Cancer 118 2390 2398 10.1002/ijc.21799 10.1002/ijc.21799 1:CAS:528:DC%2BD28XktlGitbk%3D 16425225
13. S Becker L Dossus R Kaaks 2009 Obesity related hyperinsulinaemia and hyperglycaemia and cancer development Arch Physiol Biochem 115 86 96 10.1080/13813450902878054 1:CAS:528:DC%2BD1MXhtlCqtLjK 19485704
14. DF Lazar AR Saltiel 2006 Lipid phosphatases as drug discovery targets for type 2 diabetes Nat Rev Drug Discov 5 333 342 10.1038/nrd2007 10.1038/nrd2007 1:CAS:528:DC%2BD28XjtVaksrw%3D 16582877
15. SK Kim RF Novak 2007 The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression Pharmacol Ther 113 88 120 10.1016/j.pharmthera.2006.07.004 10.1016/j.pharmthera.2006.07.004 1:CAS:528:DC%2BD2sXhsFCrtA%3D%3D 17097148
16. B Stiles Y Wang A Stahl S Bassilian WP Lee YJ Kim R Sherwin S Devaskar R Lesche MA Magnuson H Wu 2004 Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity Proc Natl Acad Sci USA 101 2082 2087 10.1073/pnas.0308617100 10.1073/pnas.0308617100 1:CAS:528: DC%2BD2cXhs1Srsro%3D 14769918 (Pubitemid 38229018)
17. N Wijesekara D Konrad M Eweida C Jefferies N Liadis A Giacca M Crackower A Suzuki TW Mak CR Kahn A Klip M Woo 2005 Muscle-specific Pten deletion protects against insulin resistance and diabetes Mol Cell Biol 25 1135 1145 10.1128/MCB.25.3.1135-1145.2005 10.1128/MCB.25.3.1135-1145.2005 1:CAS:528:DC%2BD2MXptFyqtA%3D%3D 15657439 (Pubitemid 40165819)
18. C Kurlawalla-Martinez B Stiles Y Wang SU Devaskar BB Kahn H Wu 2005 Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue Mol Cell Biol 25 2498 2510 10.1128/MCB.25.6.2498-2510.2005 10.1128/MCB.25.6.2498-2510.2005 1:CAS:528:DC%2BD2MXisVOiu7o%3D 15743841 (Pubitemid 40354642)
19. O Gorbenko V Kuznetsov O Kukharenko A Zhyvoloup G Panasyuk I Nemazanyy V Filonenko I Gout 2004 Identification of a novel binding partners for tumor suppressor PTEN by a yeast two-hybrid approach Eksp Onkol 26 15 19 1:CAS:528:DC%2BD2cXktlans7g%3D 15112574
20. HS Ro L Zhang A Majdalawieh SW Kim X Wu PJ Lyons C Webber H Ma SP Reidy A Boudreau JR Miller P Mitchell RS McLeod 2007 Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis Obesity 15 288 302 10.1038/oby.2007.569 10.1038/oby.2007.569 1:CAS:528:DC%2BD2sXosVamtLk%3D 17299101
21. G Panasyuk I Nemazanyy V Filonenko A Zhyvoloup 2004 Large-scale yeast transformation in low-percentage agarose medium Biotechniques 36 40 44 1:CAS:528:DC%2BD2cXlvV2rtQ%3D%3D 14740481
22. O Gorbenko V Filonenko I Gout 2006 Generation and characterization of monoclonal antibodies against FABP4 Hybridoma 25 86 90 10.1089/hyb.2006.25.86 10.1089/hyb.2006.25.86 1:CAS:528:DC%2BD28Xjs1agsrs%3D 16704309
23. U Jonsson L Fagerstam B Ivarsson B Johnsson R Karlsson K Lundh S Lofas B Persson H Roos I Ronnberg 1991 Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology Biotechniques 11 620 627 1:STN:280:DyaK383gslGntA%3D%3D 1804254
24. NR Leslie A Gray I Pass EA Orchiston CP Downes 2000 Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase Biochem J 346 827 833 10.1042/0264-6021:3460827 1:CAS:528:DC%2BD3cXit1KrsLo%3D 10698713 (Pubitemid 30171047)
25. K Okumura M Zhao RA DePinho FB Furnari WK Cavenee 2005 Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor Cell Cycle 4 540 542 10.1073/pnas.0409370102 1:CAS:528:DC%2BD28XhslCqtb4%3D 15753657 (Pubitemid 40299856)
26. Y Fu N Luo MF Lopes-Virella WT Garvey 2002 The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages Atherosclerosis 165 259 269 10.1016/S0021-9150(02)00305-2 1:CAS:528:DC%2BD38Xotl2msLY%3D 12417276 (Pubitemid 35333352)
27. L Makowski GS Hotamisligil 2005 The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis Curr Opin Lipidol 16 543 548 10.1097/01.mol.0000180166.08196.07 1:CAS:528:DC%2BD2MXpslCms7c%3D 16148539
28. KT Uysal L Scheja SM Wiesbrock S Bonner-Weir GS Hotamisligil 2000 Improved glucose and lipid metabolism in genetically obese mice lacking aP2 Endocrinology 141 3388 3396 10.1210/en.141.9.3388 1:CAS:528:DC%2BD3cXmtVertrk%3D 10965911 (Pubitemid 32269028)
29. M Furuhashi G Tuncman CZ Görgün L Makowski G Atsumi E Vaillancourt K Kono VR Babaev S Fazio MF Linton R Sulsky JA Robl RA Parker GS Hotamisligil 2007 Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 Nature 447 959 965 10.1038/nature05844 10.1038/nature05844 1:CAS:528:DC%2BD2sXms1yqu7g%3D 17554340 (Pubitemid 46975747)
30. M Tsuda T Inoue-Narita A Suzuki S Itami M Blumenberg M Manabe 2009 Induction of gene encoding FABP4 in Pten-null keratinocytes FEBS Lett 583 1319 1322 10.1016/j.febslet.2009.03.030 10.1016/j.febslet.2009.03.030 1:CAS:528:DC%2BD1MXksVCktLo%3D 19303874
31. Y Horie A Suzuki E Kataoka T Sasaki K Hamada J Sasaki K Mizuno G Hasegawa H Kishimoto M Iizuka M Naito K Enomoto S Watanabe TW Mak T Nakano 2004 Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas J Clin Investig 113 1774 1783 10.1172/JCI200420513 1:CAS:528:DC%2BD2cXkvFyjsbs%3D 15199412 (Pubitemid 39071669)
32. G Boiteux I Lascombe E Roche ML Plissonnier A Clairotte H Bittard S Fauconnet 2009 A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells Int J Cancer 15 1820 1828 10.1002/ijc.24112 10.1002/ijc.24112
33. H Hackl M Maurer B Mlecnik J Hartler G Stocker D Miranda-Saavedra Z Trajanoski 2004 GOLD.db: genomics of lipid-associated disorders database BMC Genomics 5 93 10.1186/1471-2164-5-93 10.1186/1471-2164-5-93 15588328 (Pubitemid 41357640)
34. F Vazquez SR Grossman Y Takahashi MV Rokas N Nakamura WR Sellers 2001 Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex J Biol Chem 276 48627 48630 10.1074/jbc.C100556200 10.1074/jbc.C100556200 1:CAS:528:DC%2BD38Xktlaruw%3D%3D 11707428